Ragusa Robert's most recent trade in GRAIL Inc. was a trade of 94,035 Common Stock done at an average price of $33.9 . Disclosure was reported to the exchange on May 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GRAIL Inc. | Robert Ragusa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 33.93 per share. | 02 May 2025 | 94,035 | 734,627 | - | 33.9 | 3,190,608 | Common Stock |
| GRAIL Inc. | Robert Ragusa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 31.21 per share. | 11 Mar 2025 | 7,625 | 828,662 | - | 31.2 | 237,976 | Common Stock |
| GRAIL Inc. | Robert Ragusa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 31.21 per share. | 07 Mar 2025 | 7,625 | 828,662 | - | 31.2 | 237,976 | Common Stock |
| GRAIL Inc. | Robert Ragusa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 41.51 per share. | 05 Mar 2025 | 994 | 836,287 | - | 41.5 | 41,261 | Common Stock |
| Twist Bioscience Corp | Robert Ragusa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 4,472 | 23,888 (0%) | 0% | 0 | Common Stock | |
| GRAIL Inc. | Robert Ragusa | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 28.84 per share. | 03 Feb 2025 | 224,620 | 837,281 | - | 28.8 | 6,478,041 | Common Stock |
| GRAIL Inc. | Robert Ragusa | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.02 per share. | 15 Oct 2024 | 123,454 | 612,661 | - | 14.0 | 1,730,825 | Common Stock |
| GRAIL Inc. | Robert Ragusa | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 12.57 per share. | 03 Oct 2024 | 214,240 | 690,275 | - | 12.6 | 2,692,997 | Common Stock |
| GRAIL Inc. | Robert Ragusa | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 12.57 per share. | 03 Oct 2024 | 45,840 | 736,115 | - | 12.6 | 576,209 | Common Stock |
| GRAIL Inc. | Robert Ragusa | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 475,178 | 476,035 | - | 0 | Common Stock | |
| Twist Bioscience Corp | Ragusa Robert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 5,815 | 19,416 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Robert Ragusa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 8,212 | 13,601 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Robert Ragusa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 3,491 | 5,389 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Robert Ragusa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2021 | 10,588 | 0 | - | - | Director Stock Option (right to buy) | |
| Twist Bioscience Corp | Robert Ragusa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.41 per share. | 03 Mar 2021 | 10,588 | 12,486 (0%) | 0% | 30.4 | 321,981 | Common Stock |
| Twist Bioscience Corp | Robert Ragusa | Director | Sale of securities on an exchange or to another person at price $ 133.10 per share. | 03 Mar 2021 | 6,519 | 3,668 (0%) | 0% | 133.1 | 867,666 | Common Stock |
| Twist Bioscience Corp | Robert Ragusa | Director | Sale of securities on an exchange or to another person at price $ 132.15 per share. | 03 Mar 2021 | 2,299 | 10,187 (0%) | 0% | 132.2 | 303,824 | Common Stock |
| Twist Bioscience Corp | Robert Ragusa | Director | Sale of securities on an exchange or to another person at price $ 134.04 per share. | 03 Mar 2021 | 1,770 | 1,898 (0%) | 0% | 134.0 | 237,255 | Common Stock |
| Illumina Inc | Robert Ragusa | SVP, Global Quality & Ops | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2021 | 6,306 | 0 | - | - | Performance Shares | |
| Illumina Inc | Robert Ragusa | SVP, Global Quality & Ops | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2021 | 6,306 | 12,795 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Robert Ragusa | SVP, Global Quality & Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 494.24 per share. | 17 Feb 2021 | 3,178 | 9,617 (0%) | 0% | 494.2 | 1,570,695 | Common Stock |
| Illumina Inc | Robert Ragusa | SVP, Global Quality & Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 694 | 6,489 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Robert Ragusa | SVP, Global Quality & Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2021 | 4,967 | 4,967 | - | - | Performance Shares | |
| Illumina Inc | Robert Ragusa | SVP, Global Quality & Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2021 | 1,656 | 5,795 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Robert Ragusa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 973 | 973 | - | - | Director Stock Option (right to buy) | |
| Twist Bioscience Corp | Robert Ragusa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 486 | 1,898 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Robert Ragusa | SVP, Global Quality & Ops | Sale of securities on an exchange or to another person at price $ 312.35 per share. | 30 Nov 2020 | 926 | 5,876 (0%) | 0% | 312.3 | 289,236 | Common Stock |
| Illumina Inc | Robert Ragusa | SVP, Global Quality & Ops | Sale of securities on an exchange or to another person at price $ 317.44 per share. | 30 Nov 2020 | 834 | 4,262 (0%) | 0% | 317.4 | 264,745 | Common Stock |
| Illumina Inc | Robert Ragusa | SVP, Global Quality & Ops | Sale of securities on an exchange or to another person at price $ 314.74 per share. | 30 Nov 2020 | 580 | 5,246 (0%) | 0% | 314.7 | 182,549 | Common Stock |
| Illumina Inc | Robert Ragusa | SVP, Global Quality & Ops | Sale of securities on an exchange or to another person at price $ 311.34 per share. | 30 Nov 2020 | 180 | 6,802 (0%) | 0% | 311.3 | 56,041 | Common Stock |
| Illumina Inc | Robert Ragusa | SVP, Global Quality & Ops | Sale of securities on an exchange or to another person at price $ 315.76 per share. | 30 Nov 2020 | 150 | 5,096 (0%) | 0% | 315.8 | 47,364 | Common Stock |
| Illumina Inc | Robert Ragusa | SVP, Global Quality & Ops | Sale of securities on an exchange or to another person at price $ 318.83 per share. | 30 Nov 2020 | 120 | 4,142 (0%) | 0% | 318.8 | 38,260 | Common Stock |
| Illumina Inc | Robert Ragusa | SVP, Global Quality & Ops | Sale of securities on an exchange or to another person at price $ 319.50 per share. | 30 Nov 2020 | 50 | 4,092 (0%) | 0% | 319.5 | 15,975 | Common Stock |
| Illumina Inc | Robert Ragusa | SVP, Global Quality & Ops | Sale of securities on an exchange or to another person at price $ 313.14 per share. | 30 Nov 2020 | 50 | 5,826 (0%) | 0% | 313.1 | 15,657 | Common Stock |
| Illumina Inc | Robert Ragusa | SVP, Global Quality & Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.72 per share. | 05 Nov 2020 | 1,121 | 6,982 (0%) | 0% | 311.7 | 349,438 | Common Stock |
| Illumina Inc | Robert Ragusa | SVP, Global Quality & Ops | Sale of securities on an exchange or to another person at price $ 355.31 per share. | 31 Aug 2020 | 1,852 | 9,586 (0%) | 0% | 355.3 | 658,025 | Common Stock |
| Illumina Inc | Robert Ragusa | SVP, Global Quality & Ops | Sale of securities on an exchange or to another person at price $ 354.09 per share. | 31 Aug 2020 | 1,100 | 11,438 (0%) | 0% | 354.1 | 389,497 | Common Stock |
| Illumina Inc | Robert Ragusa | SVP, Global Quality & Ops | Sale of securities on an exchange or to another person at price $ 356.00 per share. | 31 Aug 2020 | 850 | 8,736 (0%) | 0% | 356.0 | 302,598 | Common Stock |
| Illumina Inc | Robert Ragusa | SVP, Global Quality & Ops | Sale of securities on an exchange or to another person at price $ 357.63 per share. | 31 Aug 2020 | 633 | 8,103 (0%) | 0% | 357.6 | 226,382 | Common Stock |
| Illumina Inc | Robert Ragusa | SVP, Global Quality & Ops | Sale of securities on an exchange or to another person at price $ 352.93 per share. | 31 Aug 2020 | 565 | 12,538 (0%) | 0% | 352.9 | 199,404 | Common Stock |